Himadri and Galaxy: Improving end markets act as catalyst for these chemical stocks

2022-08-13 14:46:43 By : Ms. Yoli Shu

Discover 5000+ schemes. Track your portfolio 24X7

MC30 is a curated basket of 30 investment-worthy mutual Fund (MF) schemes.

The new age digital currency to diversify a portfolio.

Visit this section to access live price and charts.

Learn and stay informed about cryptocurrency in India.

Learn, discover & invest in smallcases across different types to build your long term portfolio.

Explore from India`s leading investment managers and advisors curating their strategies as smallcases.

Diversify your portfolio by investing in Global brands.

Pre-configured baskets of stocks & ETFs that you can invest in with a single click. Developed by hedge funds, global asset management companies, experienced wealth management firms and portfolio managers.

Fundamental, Stock Ideas, Multibaggers & Insights

Stock & Index F&O Trading Calls & Market Analysis

Technical Call, Trading Calls & Insights

Commodity Trading Calls & Market Analysis

Currency Derivatives Trading Calls & Insights

Options Trading Advice and Market Analysis

Model portfolios, Investment Ideas, Guru Screens and Much More

Proprietary system driven Rule Based Trading calls

Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas

Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas

STOCK REPORTS BY THOMSON REUTERS

Details stock report and investment recommendation

Set price, volume and news alerts

Riding on cyclical opportunities of end market - global aluminium industry -Himadri Speciality Chemical posted yet another robust set of Q1 FY19 earnings, backed by improved product realisations for carbon products. While recovery in another important end market for the chemical industry - Indian FMCG - aided higher earnings growth for Galaxy Surfactants.

Q1 sales were up 34 percent year-on-year (YoY), backed by pricing gains (volume growth of 5 percent). While raw material cost surged 37 percent, EBITDA per tonne moved up 34 percent YoY and 9 percent quarter-on-quarter (QoQ) on account of better pricing trends for carbon black and coal tar pitch (CTP). EBITDA stands for earnings before interest, tax, depreciation and amortisation.

EBITDA margin, excluding forex effect, expanded 103 basis points YoY and 32 bps QoQ, reflecting healthy operating leverage. Moderate increase in depreciation and higher other income aided net profit growth of 53 percent.

Capacity expansion to accelerate earnings growth in near term

The company is on course to set-up a 20,000 tonne capacity for advance carbon material (ACM) in West Bengal for lithium ion batteries in phases. Currently, company is completely able to utilize 50 tonne per month capacity of ACM and, hence, expected to deliver 600 tonnes in FY19. For FY20, ACM production and sale of 5000 tonne is expected.

Full 20,000 tons capacity would be available for production by FY20-end. In case of carbon black, 60,000 tonne of additional capacity (currently: 1.2 lakh tonne) of specialty carbon black having majorly a non-tyre application would be available by Q1 FY20. Debottlenecking initiatives for CTP would lead to an one lakh tonne capacity increase (currently: 4 lakh tonne) in Q3 FY19.”

Higher volume growth (20 percent) in specialty care products and operating leverage helped improve margin. Negative other income (mark-to-market losses), however, slightly moderated profit growth.

In the medium term, we expect sales growth to mimic high single-digit volume growth, which in turn would be backed by capacity expansion (Jhagadia, Taloja and Egypt), the benefits of which would accrue in Q1 FY20. Improving utilisation of existing plants (73 percent for performance surfactants and 58 percent for special care products) would be guided by recovery in the FMCG sector.

In the recent market turmoil, the stock corrected about 30 percent from its listing highs and trades at a fair 21 times FY20e earnings. We remain positive on the stock, given its dominant market share, long term strategic partnership and R&D focus. Its sole focus on the personal care end market makes it a defensive bet in the chemical industry.

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.